Locations:
Search IconSearch
December 19, 2017/Cancer

Vitrification of Ovarian Tissue Offers New Hope for Fertility Preservation

Techniques used for both pediatric and adult patients

IMG_1966_650x450

Six-year-old Maddie1 was enjoying a typical childhood summer with her parents in 2015. But her life changed suddenly and dramatically when she was diagnosed with aplastic anemia. In severe cases like hers, when other treatments fail, bone marrow transplant is the next step.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Although often very successful, as in Maddie’s case, bone marrow transplants and other cancer treatments are gonadotoxic. They often cause hormone and menstrual abnormalities at the very least, and more often irreversible ovarian damage or premature menopause that renders young women completely infertile as adults.

Her Cleveland Clinic pediatric hematologist-oncologist Rabi Hanna, MD, decided to refer Maddie and her family to Rebecca Flyckt, MD, at Cleveland Clinic Fertility Center to discuss fertility preservation options.

Options for young girls

“Until recently, options to protect and preserve fertility in women prior to cancer treatment have been limited, including the ‘gold standard’ egg and embryo freezing,” notes Dr. Flyckt. “Plus, it is available only to postpubertal females, meaning girls and young teenagers facing cancer treatment had no options to preserve fertility.”

In addition, egg and embryo freezing may not be possible or desirable for adult women who cannot delay immediate cancer treatment or who cannot participate in expensive and involved IVF procedures for other reasons.

Promising new approach

Over the past several decades, a promising new approach to preserve fertility in younger patients and older women ineligible for egg and embryo freezing — ovarian tissue freezing using vitrification — has come to the fore.

“Although still considered experimental by professional societies such as the American Society for Reproductive Medicine, to date over 80 live births have been reported worldwide using this technique,” Dr. Flyckt reports.

Advertisement

While the number of centers offering ovarian tissue freezing for girls and women with cancer is increasing in the United States, it remains limited to centers with experimental protocols and detailed informed consent procedures in place. Children require special ethical considerations.

“Vitrification (rapid tissue freezing), similar to the most current methods used to store embryos at IVF centers, eliminates ice crystal formation, the major limiting factor in older, slow-freezing techniques,” Dr. Flyckt explains. “Ovarian tissue freezing can preserve the entire ovary, and potentially thousands of viable oocytes.”

Ovarian cortical tissue is harvested through a simple laparoscopic procedure with same-day discharge and minimal surgical risk. Tissue is frozen in strips and can be stored for decades. When the woman is ready to pursue fertility, tissue is reimplanted either at the site of the ovary (orthotopic transplant) or in an alternate location (heterotopic transplant). The tissue, secured with fine sutures, can then develop a healthy blood supply. Normal endocrine and reproductive function resumes, offering opportunity for assisted reproduction or spontaneous pregnancy. No immunosuppression is needed.

Ovary in culture awaiting dissection.

Image 1. Whole ovary in culture media awaiting dissection. Recovered from breast cancer patient hoping to preserve fertility prior to chemotherapy.

Ovary sectioned in half.

Image 2: Ovary sectioned in half. Once identified, the cortex is removed from the underlying stroma and sectioned into strips small enough to allow penetration of vitrification media but large enough to be manageable for surgical reimplantation.

Advertisement

Dissection of the first half of the ovary.

Image 3: Dissection of the first half of the ovary is complete. All usable strips of cortex have been identified and divided into equal-sized portions ready for vitrification. Remaining stroma is discarded. The same procedure will be carried out on the other half of the ovary.

Cleveland Clinic experience

Cleveland Clinic Fertility Center offers ovarian tissue freezing for adults, teenagers and prepubescent girls who face treatments that diminish fertility. A grant from VeloSano2, minimizes charges.

“The true advantages of this technique are that patients do not need to have completed puberty – so our youngest of patients are eligible,” Dr. Flyckt says. “Also, it does not delay treatment.” But she adds, “We do not know whether ultimately it will be as successful as other established techniques.”

As for Maddie? After careful discussion and planning among family and caregivers, she became the youngest patient to undergo ovarian tissue freezing process at the Cleveland Clinic. While motherhood is still very far off, she is doing extremely well, is off all major medications and living a normal life.

1A pseudonym to protect patient identity.

2Latin for “swift cure,” VeloSano is a community initiative in Cleveland, Ohio, in which participants raise money for cancer research at Cleveland Clinic through a major cycling event.

Advertisement

Related Articles

Interactive culinary medicine class
November 11, 2024/Cancer/Innovations
Integrative Oncology Improves Outcomes and Quality of Life

Combining mind, body and lifestyle practices in alignment with conventional cancer treatment

Pregnant woman
November 6, 2024/Cancer/News & Insight
Large Retrospective Study Finds Pregnancy Safe Among Young BRCA Carriers

Pregnancy did not appear to increase the risk of recurrence in patients or complications in their children

Young patient with cancer
October 25, 2024/Cancer/News & Insight
Multidisciplinary Care Model Supports Young People with Cancer

Integrated program addresses growing need for comprehensive cancer care among adolescents, young adults and adults under 50 with early onset cancers

Hurthle cell carcinoma
October 24, 2024/Cancer/News & Insight
Researchers Uncover Clues to Treating Rare Thyroid Cancer

Studies find mTOR inhibitor may play key role in treating Hurthle cell carcinoma

DNA
October 10, 2024/Cancer/Research
Blocking YES1 Protein Resensitizes Triple-Negative Breast Cancer to Treatment

Obstructing key protein allows for increased treatment uptake for taxane chemotherapy

Plan of care meeting
October 4, 2024/Cancer/Radiation Oncology
Five Years of Parallel Prospective Plan of Care Reviews

Radiation oncology department finds weekly plan of care meetings have multiple benefits

Ad